Intralesional interferon alfa-2b treatment of keratoacanthomas

J Am Acad Dermatol. 2004 Nov;51(5 Suppl):S177-80. doi: 10.1016/j.jaad.2004.05.009.

Abstract

Background: Complete excision is not always easy when a keratoacanthoma is large or located in certain anatomic areas. An effective nonsurgical treatment would be desirable in such cases.

Objective: This was a pilot study of the effects of intralesional interferon alfa-2b in the treatment of rapidly growing keratoacanthomas.

Methods: A total of 4 large, rapidly growing keratoacanthomas, which were located on the lower lip, neck, and cheeks of the 4 different patients, were treated with intralesional interferon alfa-2b injection weekly. Serial photographs were taken to observe the course of responses.

Results: All lesions resolved completely in 5 to 7 weeks with acceptable cosmetic results.

Conclusion: Intralesional interferon alfa-2b can be a treatment modality of these difficult lesions.

MeSH terms

  • Aged
  • Cheek*
  • Chills / chemically induced
  • Female
  • Fever / chemically induced
  • Follow-Up Studies
  • Humans
  • Injections, Intralesional / adverse effects
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / adverse effects
  • Keratoacanthoma / drug therapy*
  • Lip Diseases / drug therapy*
  • Male
  • Middle Aged
  • Neck*
  • Pain / etiology
  • Pilot Projects
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins